DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Amphetamine Cocaine Interaction Study - 2

Information source: The University of Texas Health Science Center, Houston
ClinicalTrials.gov processed this data on August 20, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Cocaine-Related Disorders

Intervention: Dextroamphetamine (Drug)

Phase: Phase 1

Status: Terminated

Sponsored by: The University of Texas Health Science Center, Houston

Official(s) and/or principal investigator(s):
John Grabowski, Ph.D., Principal Investigator, Affiliation: University of Texas


The purpose of this study is to evaluate results of d-amphetamine - cocaine (pharmacology)

interaction study.

Clinical Details

Official title: Amphetamine Cocaine Interaction Study

Study design: Primary Purpose: Treatment


Minimum age: 18 Years. Maximum age: 45 Years. Gender(s): Male.


Please contact site for information.

Locations and Contacts

University of Texas Health Science Center, Houston, Texas 77225, United States
Additional Information

Last updated: May 17, 2012

Page last updated: August 20, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017